https://www.oncologynurseadvisor.com Mon, 09 Dec 2019 20:40:57 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png https://www.oncologynurseadvisor.com 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/treatment-strategy-optimization-for-lymphoma-in-hiv-positive-patients/ Mon, 09 Dec 2019 20:40:55 +0000 https://www.oncologynurseadvisor.com/?p=70577 Cancer, particularly non-Hodgkin lymphoma, remains a leading cause of death in patients with HIV who are being treated with antiretroviral therapy.]]> https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/venous-and-arterial-thrombosis-incidence-and-risk-factors-with-ibrutinib-treatment/ Thu, 17 Oct 2019 16:05:37 +0000 https://www.oncologynurseadvisor.com/?p=68484 Researchers found a low incidence of thrombotic events in patients receiving ibrutinib, though some patients still experienced bleeding. ]]>